There is a lot of global interest in Advanced Therapy Medicinal Products (ATMP). These products involve regenerative medicine, such as therapies targeting cells, genes, and tissues, all of which build or replace organs in the body. For many years, RISE has collaborated with biotech company VERIGRAFT on a new method for personalised blood vessels for the transplantation of veins with valves.  

Associate Professor Joakim Håkansson, researcher at RISE, will hold a presentation together with Dr Petter Björquist, CEO at VERIGRAFT AB, about advanced therapies with individualized blood vessels in focus. 

The presentations will encompass a general introduction to advanced therapies (cell-therapy, gene-therapy and tissue engineering), why we want to develop individualized drugs, and show the process of a vein grafts product from research and development to clinical trial.